Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome.
Reads0
Chats0
TLDR
Data suggest that in OSAS patients the high ANP plasma concentration is responsible for the observed elevated diuresis and sodium excretion, and these effects are rapidly reversible, as they are reversed during the first CPAP treated night.Abstract:
Nocturnal polyuria with repeated micturitions during the night is a clinically evident feature of obstructive sleep apnea syndrome (OSAS). These effects are reversed by continuous positive airway pressure (CPAP). There is some evidence that atrial natriuretic peptide (ANP) and catecholaminergic activity may be implicated in the pathogenesis of these symptoms. We studied these biochemical parameters in six patients with severe OSAS during two nights: the first (basal) in their normal conditions and the second during CPAP treatment. CPAP treatment reversed apnea episodes in all our patients. A significant (p less than 0.035) reduction of nocturnal urine volume (from 902 +/- 297 to 447 +/- 130 ml; mean +/- SD), sodium excretion (from 150 +/- 33 to 89 +/- 35 mEq/12 h), noradrenaline excretion (from 95 +/- 101 to 52 +/- 16 micrograms/g creatinine), noradrenaline plasma concentrations (from 325 +/- 96 to 259 +/- 75 pg/ml), ANP plasma concentrations (from 35 +/- 20 to 19 +/- 5 pg/ml) was observed during the night under CPAP application. These data suggest that in OSAS patients the high ANP plasma concentration is responsible for the observed elevated diuresis and sodium excretion. These effects are rapidly reversible, as they are reversed during the first CPAP treated night.read more
Citations
More filters
Journal ArticleDOI
Sleep Apnea and Cardiovascular Disease
Journal ArticleDOI
Nocturnal Continuous Positive Airway Pressure Decreases Daytime Sympathetic Traffic in Obstructive Sleep Apnea
Krzysztof Narkiewicz,Masahiko Kato,Bradley G. Phillips,Catherine A. Pesek,Diane E. Davison,Virend K. Somers +5 more
TL;DR: CPAP treatment decreases muscle sympathetic traffic in patients with OSA, and this effect of CPAP is evident only after an extended duration of therapy.
Journal ArticleDOI
Effects of obstructive sleep apnea on endothelin-1 and blood pressure.
Bradley G. Phillips,Krzysztof Narkiewicz,Catherine A. Pesek,William G. Haynes,Mark Eric Dyken,Virend K. Somers +5 more
TL;DR: Nightly changes in hemodynamics, oxygen saturation, the apnea-hypopnea index, circulating endothelin-1, norepinephrine and plasma renin activity in 22 patients with severe obstructive sleep apnea before and after successful therapy using continuous positive airway pressure therapy are evaluated.
Journal ArticleDOI
Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure
TL;DR: OSA may contribute to impaired left-ventricular function in some patients with dilated cardiomyopathy of otherwise unknown origin, and reversal of OSA by NCPAP can lead to significant improvement in LVEF.
Journal ArticleDOI
Hypertension, cardiac arrhythmias, myocardial infarction, and stroke in relation to obstructive sleep apnea.
TL;DR: Evidence exists linking REM sleep to an increased risk of myocardial ischemia, infarction, sudden death, and stroke in men who habitually snore, and there is reasonable information indicating excessive mortality in the absence of treatment.